Norges Bank Silk Road Medical Inc Transaction History

Norges Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$16.95 - $27.04 $1.84 Million - $2.94 Million	108,600 New	108,600 $2.94 Million
Q2 2023 Aug 14, 2024	SELL	$29.76 - $46.14 $2.33 Million - $3.61 Million	-78,200 Reduced 72.01%	30,400 $987,000
Q1 2023 May 15, 2024	BUY	$38.09 - $57.79 $11.3 Million - $17.1 Million	295,500 New	295,500 $11.6 Million
Q4 2022 Feb 14, 2023	BUY	$40.54 - $56.2 $3.95 Million - $5.47 Million	97,400 New	97,400 $5.15 Million
Q1 2022 May 09, 2022	SELL	$29.24 - $44.06 $2.06 Million - $3.1 Million	-70,341 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$39.32 - $61.61 $2.77 Million - $4.33 Million	70,341 New	70,341 $3 Million

3.48M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.